Pfizer/BioNTech Covid-19 vaccine safe for primary schoolkids


By AGENCY

Clinical trial results have demonstrated that the Pfizer-BioNTech Covid-19 vaccine is safe to be used in children aged five to 11 years. — AFP

Pfizer and BioNTech said on Sept 20 (2021) that clinical trial results showed their Covid-19 vaccine is safe and produces a robust immune response in children aged five to 11.

The vaccine would be administered at a lower dosage than for people over 12, they said.

Start your ads-free experience now!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Health

Debunking male misconceptions about sex
Watch out for your heart when you take xylitol
What happens when you’re allergic to drugs
How this pharmaceutical company tricked doctors
Seniors, increase your step count for better health
Salt: A potential trigger for eczema
Singing helped this stroke patient regain his voice
Picnic tips: Ensuring your food is safe to eat
Soothe your cough with liquorice
Can infants take cow’s milk?

Others Also Read